Q2 Earnings Estimate for ACHC Issued By Leerink Partnrs

Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) - Research analysts at Leerink Partnrs issued their Q2 2025 earnings estimates for Acadia Healthcare in a research report issued to clients and investors on Wednesday, May 14th. Leerink Partnrs analyst W. Mayo anticipates that the company will post earnings of $0.61 per share for the quarter. The consensus estimate for Acadia Healthcare's current full-year earnings is $3.38 per share. Leerink Partnrs also issued estimates for Acadia Healthcare's Q3 2025 earnings at $0.78 EPS, Q4 2025 earnings at $0.79 EPS, Q1 2026 earnings at $0.49 EPS, Q2 2026 earnings at $0.72 EPS, Q3 2026 earnings at $0.87 EPS, FY2026 earnings at $2.91 EPS and FY2027 earnings at $3.32 EPS.

Several other analysts have also recently weighed in on the stock. KeyCorp reduced their target price on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a report on Wednesday, May 14th. Barclays reduced their target price on shares of Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating on the stock in a report on Wednesday, May 14th. Bank of America dropped their target price on Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a report on Friday, February 28th. Guggenheim initiated coverage on Acadia Healthcare in a report on Wednesday, April 9th. They issued a "buy" rating and a $36.00 target price on the stock. Finally, Mizuho dropped their target price on Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating on the stock in a report on Wednesday, May 14th. One analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $47.94.

Acadia Healthcare Stock Up 0.5%

NASDAQ:ACHC traded up $0.12 during midday trading on Monday, reaching $25.20. The company had a trading volume of 1,402,506 shares, compared to its average volume of 1,711,302. The firm has a market capitalization of $2.32 billion, a price-to-earnings ratio of 8.26, a PEG ratio of 1.46 and a beta of 1.01. The stock's fifty day simple moving average is $26.06 and its 200-day simple moving average is $35.30. Acadia Healthcare has a 12-month low of $20.36 and a 12-month high of $82.41. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings data on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, beating analysts' consensus estimates of $0.35 by $0.05. The firm had revenue of $770.51 million during the quarter, compared to analysts' expectations of $769.90 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business's quarterly revenue was up .3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.84 earnings per share.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. JPMorgan Chase & Co. increased its position in Acadia Healthcare by 17.0% during the third quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company's stock worth $198,258,000 after buying an additional 454,044 shares during the period. SG Americas Securities LLC raised its position in Acadia Healthcare by 713.3% during the 4th quarter. SG Americas Securities LLC now owns 110,866 shares of the company's stock worth $4,396,000 after buying an additional 97,235 shares during the last quarter. Beach Point Capital Management LP acquired a new position in Acadia Healthcare during the 4th quarter worth approximately $14,097,000. Sterling Capital Management LLC increased its position in Acadia Healthcare by 59.1% during the 4th quarter. Sterling Capital Management LLC now owns 5,456 shares of the company's stock worth $216,000 after purchasing an additional 2,026 shares during the period. Finally, Stephens Investment Management Group LLC increased its position in Acadia Healthcare by 24.9% during the 4th quarter. Stephens Investment Management Group LLC now owns 1,475,166 shares of the company's stock worth $58,490,000 after purchasing an additional 294,210 shares during the period.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.